Comparative Study of Efficacy of Oral Terbinafine and Oralitraconazole in Tinea Corporis/Tinea Cruris Infection

被引:1
作者
Brigida, S. [1 ]
Elizabeth, Arul Amutha [1 ]
机构
[1] Bharath Inst Higher Educ & Res, Dept Pharmacol, Sree Balaji Med Coll & Hosp, Chennai, Tamil Nadu, India
关键词
Dermatophytoses; itraconazole; terbinafine; steroid; DOUBLE-BLIND; CHRONIC DERMATOPHYTOSIS; ITRACONAZOLE; EPIDEMIOLOGY; RESISTANCE; THERAPY;
D O I
10.9734/JPRI/2021/v33i20A31352
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dermatophytoses which are superficial fungal infections of the skin, hair, and nail are among the most common infective dermatoses seen in dermatology outpatient clinics. Today, we are facing an onslaught of chronic and recurrent dermatophytosis in volumes never encountered previously. Itraconazole was found to be the better antifungal in terms of clinical cure,mycological clearance and less need for extension of treatment than Terbinafine. Overall, oral Itraconazole 200 mg/day for 2 weeks proved to be a better agent with excellent and significantly better cure rates than oral Terbinafine 500mg/day for 2 weeks. With Itraconazole, the contra-indications, drug interactions must be kept in mind to prevent loss of efficacy/ potentially hazardous interactions. Both drugs had a good safety profile and few minor adverse events. The reasons for extension of treatment comprise chronicity, previous treatment with OTC steroid preparations, and misuse of systemic antifungal drugs, diabetes, and obesity. Poor personal practices and hygiene also havetheir contribution. Significant associations were also noted between diabetes and chronicity.
引用
收藏
页码:94 / 105
页数:12
相关论文
共 32 条
  • [11] Epidemiological trends in skin mycoses worldwide
    Havlickova, Blanka
    Czaika, Viktor A.
    Friedrich, Markus
    [J]. MYCOSES, 2008, 51 : 2 - 15
  • [12] A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil®) with fluconazole (Diflucan®) in the treatment of onychomycosis
    Havu, V
    Heikkilä, H
    Kuokkanen, K
    Nuutinen, M
    Rantanen, T
    Saari, S
    Stubb, S
    Suhonen, R
    Turjanmaa, K
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (01) : 97 - 102
  • [14] ITRACONAZOLE IN THE MANAGEMENT OF CHRONIC DERMATOPHYTOSIS
    HAY, RJ
    CLAYTON, YM
    MOORE, MK
    MIDGELY, G
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 23 (03) : 561 - 564
  • [16] Kannan P, 2006, Indian J Med Microbiol, V24, P212
  • [17] Update on antifungal resistance
    Klepser, ME
    Ernst, EJ
    Pfaller, MA
    [J]. TRENDS IN MICROBIOLOGY, 1997, 5 (09) : 372 - 375
  • [18] Kumar A, 2013, IJBR, V4, P7
  • [19] Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine
    Mukherjee, PK
    Leidich, SD
    Isharn, N
    Leitner, I
    Ryder, NS
    Ghannoum, MA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) : 82 - 86
  • [20] Nigam P. K., 2015, Our Dermatology Online, V6, P212, DOI 10.7241/ourd.20152.58